News Related to Osteoporosis
-
FDA Panel: Long-Used Osteoporosis Drug Too Risky
March 7, 2013 -- An FDA panel voted to stop recommending calcitonin salmon for the treatment of osteoporosis in women who are at least five years past menopause. The committee voted 12-9 against continued marketing of the drug, citing lack of benefit and concerns about a cancer risk. Calcitonin salm
Read Full Article -
Moderate Drinking May Help Older Women's Bones
July 11, 2012 -- Women who drink alcohol moderately may be doing their bones a favor, new research suggests. "Moderate alcohol as a component of a healthy lifestyle that includes a balanced diet and physical activity may lower the risk of osteoporosis," researcher Urszula Iwaniec, PhD, associate pro
Read Full Article -
Vitamin D, Calcium for Fracture Risk Questioned
June 12, 2012 -- Vitamin D and calcium supplements may not stave off osteoporosis-related bone fractures in most older women, according to new recommendations from the U.S. Preventive Services Task Force. What's more, there is not enough evidence to say whether supplements of vitamin D, with or with
Read Full Article -
FDA OKs Generic Boniva for Bone Loss
March 19, 2012 -- Three generic drugmakers may now sell their own versions of the bone-loss drug Boniva, the FDA ruled today. Boniva, known by the generic name ibandronate, is a once-a-month pill prescribed to prevent or to treat bone loss from osteoporosis. The FDA officially approves Boniva only f
Read Full Article -
Drug-Delivery Microchip Could Replace Daily Injections
Feb. 16, 2012 -- An experimental, implanted drug-delivery microchip that releases medication on command from an external wireless control could one day free patients from daily injections and improve treatment compliance. Results from the first human study of the programmable microchip were reported
Read Full Article -
Osteoporosis Medication Linked to Unusual Thigh Fractures
Feb. 8, 2012 -- Some drugs used to strengthen bones may increase the risk of an unusual type of fracture if patients take them for many years, a new study shows. Overall, most people with osteoporosis, a loss of bone density over time, will suffer fewer broken bones if they take bisphosphonates, a c
Read Full Article -
Bone Density at Age 67 May Predict Later Bone Health
Jan. 18, 2012 -- Women with normal or nearly normal bone density at age 67 may not need repeat testing for about 15 years, according to a new study of nearly 5,000 women. If bone density was normal or nearly so at the study start, "only 10% developed osteoporosis over 15 years,'' says study research
Read Full Article -
FDA Panel: Osteoporosis Drugs Need Better Labels
Sept. 9, 2011 -- Labels on bisphosphonates, a type of medication used to treat and prevent osteoporosis, should further clarify how long patients can take them, an FDA advisory panel voted today. But the panel backed off giving any specific time limits. Bisphosphonates include Aclasta, Actonel, Alte
Read Full Article -
FDA: Osteoporosis Drug Reclast Raises Kidney Failure Risk
Sept. 1, 2011 -- The FDA warns that the osteoporosis drug Reclast (zoledronic acid) raises the risk of kidney failure. The warning is targeted at patients who already suffer from kidney impairment. It's also aimed at those who are taking potentially kidney-damaging (nephrotoxic) medications or diure
Read Full Article -
Facial Wrinkles Linked to Lower Bone Density
June 7, 2011 -- Women with deeply furrowed brows in early menopause may also have troubled bones, an early report of a new study shows. Researchers measured the number and depth of facial wrinkles and the skin firmness of 114 women who were within three years of their last menstrual period. Bone den
Read Full Article
Today on WebMD
Health Solutions From Our Sponsors
©2005-2013 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.